Ácido tranexámico en cirugía cardíaca: ¿las dosis bajas son suficientes?

Revista Española de Anestesiología y Reanimación - Tập 68 - Trang 576-583 - 2021
J.J. Peña Borras1, A. Pajares Moncho2, J. Puig1,3, E. Mateo Rodríguez1, C. López Forte2, L. Peña Pérez4, J. Moreno Pachón1, T. Gabaldón Conejos1, J. Pérez Artacho2, C. Ferrer Gómez1, A. Férez Martí5, M. López Cantero2, J. de Andrés Ibáñez1,3
1Servicio de Anestesiología y Reanimación, Consorcio Hospital General Universitario de Valencia, Valencia, España
2Servicio de Anestesiología y Reanimación, Hospital Universitario y Politécnico La Fe, Valencia, España
3Departamento de Cirugía, Facultad de Medicina y Odontología, Universidad de Valencia, Valencia, España
4Centre for Haematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Suecia
5Servicio de Análisis Clínicos, Hospital General Universitario de Valencia, Valencia, España

Tài liệu tham khảo

Williams, 2017, Practical use of thromboelastometry in the management of perioperative coagulopathy and bleeding, Transfus Med Rev., 31, 11, 10.1016/j.tmrv.2016.08.005 Raphael, 2019, Society of Cardiovascular Anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients [published correction appears in J Cardiothorac Vasc Anesth. 2020;34:840-841], J Cardiothorac Vasc Anesth, 33, 2887, 10.1053/j.jvca.2019.04.003 Ranucci, 2015, Hemostatic and thrombotic issues in cardiac surgery, Semin Thromb Hemost., 41, 84, 10.1055/s-0034-1398383 Maeda, 2018, Evaluating the effect on mortality of a no-tranexamic acid (TXA) policy for cardiovascular surgery, J Cardiothorac Vasc Anesth., 32, 1627, 10.1053/j.jvca.2017.10.018 Taam, 2020, Current evidence and future directions of tranexamic acid use efficacy, and dosing for major surgical procedures, J Cardiothorac Vasc Anesth., 34, 782, 10.1053/j.jvca.2019.06.042 Hessel, 2019, What's new in cardiopulmonary bypass, J Cardiothorac Vasc Anesth., 33, 2296, 10.1053/j.jvca.2019.01.039 Gerstein, 2017, Antifibrinolytic agents in cardiac and noncardiac surgery: A comprehensive overview and update, J Cardiothorac Vasc Anesth., 31, 2183, 10.1053/j.jvca.2017.02.029 Picetti, 2019, What concentration of tranexamic acid is needed to inhibit fibrinolysis? A systematic review of pharmacodynamics studies, Blood Coagul Fibrinolysis., 30, 1, 10.1097/MBC.0000000000000789 Lecker, 2016, Tranexamic acid-associated seizures: Causes and treatment, Ann Neurol., 79, 18, 10.1002/ana.24558 Pagano, 2018, 2017 EACTS/EACTA guidelines on patient blood management for adult cardiac surgery, Eur J Cardiothorac Surg., 53, 79, 10.1093/ejcts/ezx325 Dowd, 2002, Pharmacokinetics of tranexamic acid during cardiopulmonary bypass, Anesthesiology., 97, 390, 10.1097/00000542-200208000-00016 Horrow, 1995, The dose-response relationship of tranexamic acid, Anesthesiology., 82, 383, 10.1097/00000542-199502000-00009 Görlinger, 2019, The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management, Korean J Anesthesiol., 72, 297, 10.4097/kja.19169 Dyke, 2014, Universal definition of perioperative bleeding in adult cardiac surgery, J Thorac Cardiovasc Surg., 147, 1458, 10.1016/j.jtcvs.2013.10.070 Fiechtner, 2001, Plasma tranexamic acid concentrations during cardiopulmonary bypass, Anesth Analg., 92, 1131, 10.1097/00000539-200105000-00010 Koster, 2015, Antifibrinolytic therapy for cardiac surgery: An update, Anesthesiology., 123, 21, 10.1097/ALN.0000000000000688 Myles, 2017, Tranexamic acid in patients undergoing coronary-artery surgery [published correction appears in N Engl J Med. 2018;378:782], N Engl J Med., 376, 136, 10.1056/NEJMoa1606424 Longstaff, 2018, Measuring fibrinolysis: From research to routine diagnostic assays, J Thromb Haemost., 16, 652, 10.1111/jth.13957 Levy, 2018, Antifibrinolytic therapy and perioperative considerations, Anesthesiology., 128, 657, 10.1097/ALN.0000000000001997 Faraoni, 2015, Experimental model of hyperfibrinolysis designed for rotational thromboelastometry in children with congenital heart disease, Blood Coagul Fibrinolysis., 26, 290, 10.1097/MBC.0000000000000238 Ng, 2015, Tranexamic acid: A clinical review, Anaesthesiol Intensive Ther., 47, 339, 10.5603/AIT.a2015.0011 Faraoni, 2014, Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: A randomised, controlled study, Eur J Anaesthesiol., 31, 491, 10.1097/EJA.0000000000000051 Ide, 2010, Lessons from the aprotinin saga: Current perspective on antifibrinolytic therapy in cardiac surgery, J Anesth., 24, 96, 10.1007/s00540-009-0866-9 Shi, 2020, Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): Rationale, design, and study protocol of a multicenter randomized controlled trial, Am Heart J., 222, 147, 10.1016/j.ahj.2019.09.010 Guo, 2019, Different dose regimes and administration methods of tranexamic acid in cardiac surgery: A meta-analysis of randomized trials, BMC Anesthesiol., 19, 129, 10.1186/s12871-019-0772-0 Besser, 2015, Haemostatic management of cardiac surgical haemorrhage, Anaesthesia., 70, 87, 10.1111/anae.12898 Paparella, 2004, Coagulation disorders of cardiopulmonary bypass: A review, Intensive Care Med., 30, 1873, 10.1007/s00134-004-2388-0 Zaky, 2017, Thromboelastometry versus rotational thromboelastography in cardiac surgery, Semin Cardiothorac Vasc Anesth., 21, 206, 10.1177/1089253217697146 Draxler, 2019, Tranexamic acid modulates the immune response and reduces postsurgical infection rates, Blood Adv., 3, 1598, 10.1182/bloodadvances.2019000092 Mou, 2018, Blood clot parameters: Prejudgment of fibrinolysis in thromboelastography, Clin Chim Acta., 479, 94, 10.1016/j.cca.2018.01.023